197 related articles for article (PubMed ID: 16847147)
1. C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells.
Zhong Y; Li SH; Liu SM; Szmitko PE; He XQ; Fedak PW; Verma S
Hypertension; 2006 Sep; 48(3):504-11. PubMed ID: 16847147
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
Chen J; Huang L; Song M; Yu S; Gao P; Jing J
J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
Mahajan N; Bahl A; Dhawan V
Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products.
Chen J; Jin J; Song M; Dong H; Zhao G; Huang L
Gene; 2012 Apr; 496(2):128-35. PubMed ID: 22301267
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Takeuchi M
Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
[TBL] [Abstract][Full Text] [Related]
11. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.
Lohwasser C; Neureiter D; Weigle B; Kirchner T; Schuppan D
J Invest Dermatol; 2006 Feb; 126(2):291-9. PubMed ID: 16374460
[TBL] [Abstract][Full Text] [Related]
12. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
[TBL] [Abstract][Full Text] [Related]
13. Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage.
Li H; Wu W; Sun Q; Liu M; Li W; Zhang XS; Zhou ML; Hang CH
Brain Res; 2014 Jan; 1543():315-23. PubMed ID: 24291745
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein stimulates RAGE expression in human coronary artery endothelial cells in vitro via ROS generation and ERK/NF-κB activation.
Zhong Y; Cheng CF; Luo YZ; Tian CW; Yang H; Liu BR; Chen MS; Chen YF; Liu SM
Acta Pharmacol Sin; 2015 Apr; 36(4):440-7. PubMed ID: 25832424
[TBL] [Abstract][Full Text] [Related]
16. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.
Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE
Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
18. Blockade of angiotensin II receptors reduces the expression of receptors for advanced glycation end products in human endothelial cells.
Fujita M; Okuda H; Tsukamoto O; Asano Y; Hirata YL; Kim J; Miyatsuka T; Takashima S; Minamino T; Tomoike H; Kitakaze M
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):e138-42. PubMed ID: 16888237
[TBL] [Abstract][Full Text] [Related]
19. Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.
Ballinger ML; Thomas MC; Nigro J; Ivey ME; Dilley RJ; Little PJ
Kidney Int; 2005 Dec; 68(6):2756-65. PubMed ID: 16316350
[TBL] [Abstract][Full Text] [Related]
20. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
